ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
5,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
5,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
6,1,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
7,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
8,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
8,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
9,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,Y
9,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
9,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
10,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
10,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
11,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
12,1,Myopathy,Myopathies,Muscle disorders,Musc,N
13,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
14,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
14,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
14,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
14,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
15,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
15,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
15,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
16,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
16,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
17,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
17,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
17,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,4,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
18,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
18,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
18,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
19,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
20,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
21,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
21,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
22,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
22,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
22,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
23,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
24,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
25,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
25,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
25,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
25,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
25,5,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
26,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
26,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
26,3,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
27,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
27,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
28,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
29,1,Bone marrow oedema syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
30,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
30,3,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
30,4,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
30,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
31,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
31,2,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
31,3,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
32,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
32,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
33,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
34,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
34,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,4,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
34,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
35,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
35,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
35,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
35,4,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
35,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
35,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
35,7,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
36,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
36,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
37,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
37,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
37,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
37,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
38,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
39,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
39,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
39,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
39,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
39,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
39,6,Wrong dose,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
40,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
41,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
41,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
41,3,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
41,4,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
41,5,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
41,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
41,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
42,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
42,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
42,3,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
42,4,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
42,5,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
42,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
42,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
43,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
43,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
43,3,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
43,4,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
43,5,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
43,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
43,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
